Conference Coverage

This channel highlights DAIC's coverage of numerous key cardiology and medical imaging conferences each year. These include ACC, AHA, ASE, ASNC, EuroPCR, ECR, HIMSS, HRS, RSNA, SCAI, SCCT, TCT, and VIVA.

Despite greater weight loss in women, the improvement in HF symptoms was similar between sexes, suggesting semaglutide's heart failure benefits may be, in part, independent of weight loss
News | Cardiovascular Clinical Studies
Semaglutide Leads to Greater Weight Loss in Women than Men with HF, Improves HF Symptoms in Both Sexes

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
Editor-in-Chief Dr. Harlan Krumholz outlines vision for new era of JACC
News | Cardiovascular Business
JACC to Serve Cardiovascular Community, Shape Future Under New Editor

June 26, 2024 — The first issue of JACC, the flagship journal of the American College of Cardiology, under new Editor-in ...

Home June 26, 2024
Home
Nano-X Imaging (Nanox)
News | Artificial Intelligence
Data Supporting Nanox.AI Cardiac Solution to Be Presented at 19th Annual Meeting of the Society of Cardiovascular Computed Tomography

June 25, 2024 — Nano-X Imaging (Nanox), an innovative medical imaging technology company, today announced that data from ...

Home June 25, 2024
Home
Aakriti Gupta, MD. Photo by Cedars-Sinai
News | Cardiovascular Business
Smidt Heart Institute Experts Selected to Join JACC Editorial Team

June 24, 2024 — Aakriti Gupta, MD, and Michelle Kittleson, MD, PhD, cardiologists in the Smidt Heart Institute at Cedars ...

Home June 24, 2024
Home
News | Mobile C-Arms
Philips Showcases FDA-approved Zenition 90 Motorized at the 2024 Vascular Annual Meeting

June 19, 2024 —Royal Philips, a global leader in health technology, today announced the launch of Philips Image Guided ...

Home June 20, 2024
Home
Modern therapies have extended the lives of many cancer patients; however, survivors often live with chronic health conditions, including cardiovascular disease
News | Cardio-oncology
Study Finds Air Pollution Can Increase Cardiovascular Risk for Cancer Patients

June 19, 2024 — Modern therapies have extended the lives of many cancer patients; however, survivors often live with ...

Home June 19, 2024
Home
Despite significant advances in prevention and treatment, Black Americans have higher risk of cardiovascular death
News | Heart Failure
JACC Report Card Highlights Inequities in CV Care, Death Rates

June 18, 2024 — As we commemorate Juneteenth 2024, JACC, the flagship journal of the American College of Cardiology, has ...

Home June 18, 2024
Home
At least 6 in 10 adults in an older, more diverse U.S. population could be affected by cardiovascular disease within the next 30 years, according to two new science reports from the American Heart Association (AHA).
News | AHA
Heart Disease and Stroke Could Affect at Least 60% of Adults in U.S. by 2050, According to American Heart Association Advisories

June 18, 2024 — At least 6 in 10 adults in an older, more diverse U.S. population could be affected by cardiovascular ...

Home June 18, 2024
Home
Medical device company Visura Technologies, Inc. has announced the TEECADE mini, an initiative for the next innovation in transesophageal echocardiography (TEE) imaging technology. The company, led by President & CEO Christine Horton, will be participating in the American Society of Echocardiography Scientific Sessions (ASE 2024) to be held June 14-16 in Portland, OR.
News | Transesophageal Echo (TEE)
Visura Technologies to Feature TEECAD mini for Use with Smaller Transesophageal Echocardiography (TEE) Probes During ASE 2024

June 13, 2024 — Visura Technologies, Inc., a privately owned medical device company, has announced the TEECADE mini, an ...

Home June 13, 2024
Home
Royal Philips has announced its AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology, reporting that results of a new scientific abstract being presented at the American Society of Echocardiography (ASE 2024) annual meeting, June 14-16 in Portland, OR, will demonstrate how first-of-kind AI algorithms co-developed with Philips provide highly accurate detection of regional wall motion abnormalities (RWMA) on echocardiography.
News | ASE
Results Involving Philips FDA-cleared AI-enabled Cardiovascular Ultrasound Platform to be Presented at American Society of Echocardiography Scientific Sessions, ASE 2024

June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help ...

Home June 12, 2024
Home
A newly developed radiotracer can generate high quality and readily interpretable images of cardiac amyloidosis
News | SPECT-CT
Novel Radiotracer Produces High Quality Images of “Alzheimer’s Disease of the Heart”

June 11, 2024 — A newly developed radiotracer can generate high quality and readily interpretable images of cardiac ...

Home June 11, 2024
Home
A Review of the 2024 Heart Rhythm Society Conference
Feature | HRS | By Lars Thording, PhD
HRS 2024: Innovation Meets Reality

Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient ...

Home June 11, 2024
Home
New expert consensus from the Society of Cardiovascular Computed Tomography (SCCT) reviews previously published qualitative and semi-quantitative measurements
News | Cardiac Imaging
New Expert Consensus Turns Cardiac CT Imaging into Measurable Standards

June 10, 2024 —  New expert consensus from the Society of Cardiovascular Computed Tomography (SCCT) reviews previously ...

Home June 10, 2024
Home
Xylitol is a common zero-calorie sweetener found in sugar-free candy and toothpaste
News | Hypertension
Study: Young Athletes at Risk for Elevated Blood Pressure Rates, Future Cardiovascular Complications

June 6, 2024 — A substantial portion of young athletes are at risk of hypertension, according to a study presented at ...

Home June 06, 2024
Home
Analysis adds to the body of evidence differentiating INPEFA as a dual oral inhibitor of SGLT2 and SGLT1
News | Pharmaceuticals
New Post-Hoc Analysis of Pooled Phase 3 Data Shows That Inpefa (Sotagliflozin) Reduced Risk of Heart Failure Events in Patients With Preserved Ejection Fraction

June 5, 2024 —  Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced a new post-hoc analysis of clinical data ...

Home June 05, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now